Annual Revenue
$31.57 M
+$9.90 M+45.69%
December 31, 2023
Summary
- As of February 7, 2025, SLN annual revenue is $31.57 million, with the most recent change of +$9.90 million (+45.69%) on December 31, 2023.
- During the last 3 years, SLN annual revenue has risen by +$24.54 million (+349.01%).
- SLN annual revenue is now at all-time high.
Performance
SLN Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue
$1.49 M
+$731.50 K+96.95%
September 1, 2024
Summary
- As of February 7, 2025, SLN quarterly revenue is $1.49 million, with the most recent change of +$731.50 thousand (+96.95%) on September 1, 2024.
- Over the past year, SLN quarterly revenue has dropped by -$1.12 million (-43.00%).
- SLN quarterly revenue is now -90.56% below its all-time high of $15.74 million, reached on March 31, 2024.
Performance
SLN Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM Revenue
$20.58 M
-$2.06 M-9.09%
September 1, 2024
Summary
- As of February 7, 2025, SLN TTM revenue is $20.58 million, with the most recent change of -$2.06 million (-9.09%) on September 1, 2024.
- Over the past year, SLN TTM revenue has dropped by -$10.79 million (-34.39%).
- SLN TTM revenue is now -40.84% below its all-time high of $34.79 million, reached on June 30, 2023.
Performance
SLN TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
SLN Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +45.7% | -43.0% | -34.4% |
| 3 y3 years | +349.0% | -73.5% | -5.7% |
| 5 y5 years | - | -73.5% | -5.7% |
SLN Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +84.9% | -90.6% | +97.0% | -40.8% | +20.6% |
| 5 y | 5-year | at high | >+9999.0% | -90.6% | +97.0% | -40.8% | +701.2% |
| alltime | all time | at high | >+9999.0% | -90.6% | +97.0% | -40.8% | +701.2% |
Silence Therapeutics Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $1.49 M(+97.0%) | $20.58 M(-9.1%) |
| Jun 2024 | - | $754.50 K(-95.2%) | $22.64 M(-32.0%) |
| Mar 2024 | - | $15.74 M(+503.6%) | $33.28 M(+6.1%) |
| Dec 2023 | $31.57 M(+45.7%) | $2.61 M(-26.4%) | $31.37 M(-8.7%) |
| Sep 2023 | - | $3.54 M(-68.9%) | $34.37 M(-1.2%) |
| Jun 2023 | - | $11.40 M(-17.6%) | $34.79 M(+24.4%) |
| Mar 2023 | - | $13.83 M(+146.7%) | $27.98 M(+28.2%) |
| Dec 2022 | $21.67 M(+26.9%) | $5.60 M(+41.2%) | $21.83 M(+4.8%) |
| Sep 2022 | - | $3.97 M(-13.4%) | $20.83 M(-1.8%) |
| Jun 2022 | - | $4.58 M(-40.3%) | $21.21 M(+3.9%) |
| Mar 2022 | - | $7.68 M(+66.8%) | $20.41 M(+19.6%) |
| Dec 2021 | $17.08 M(+142.9%) | $4.60 M(+5.8%) | $17.06 M(+9.7%) |
| Sep 2021 | - | $4.35 M(+15.3%) | $15.55 M(+12.9%) |
| Jun 2021 | - | $3.78 M(-12.9%) | $13.77 M(+37.8%) |
| Mar 2021 | - | $4.33 M(+40.1%) | $10.00 M(+76.5%) |
| Dec 2020 | $7.03 M(+2156.8%) | $3.09 M(+20.4%) | $5.66 M(+120.4%) |
| Sep 2020 | - | $2.57 M | $2.57 M |
| Dec 2019 | $311.60 K(+1405.3%) | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2017 | $20.70 K(-98.0%) | - | - |
| Dec 2016 | $1.04 M(+4123.9%) | - | - |
| Dec 2014 | $24.70 K(-86.5%) | - | - |
| Dec 2013 | $183.10 K(-29.1%) | - | - |
| Dec 2012 | $258.30 K(-76.8%) | - | - |
| Dec 2011 | $1.11 M(-69.5%) | - | - |
| Dec 2010 | $3.65 M(+35.2%) | - | - |
| Dec 2009 | $2.70 M(-33.9%) | - | - |
| Dec 2008 | $4.09 M(-49.6%) | - | - |
| Dec 2007 | $8.10 M(+125.6%) | - | - |
| Dec 2006 | $3.59 M(+287.6%) | - | - |
| Dec 2005 | $926.10 K(+217.8%) | - | - |
| Dec 2004 | $291.40 K(-86.8%) | - | - |
| Dec 2003 | $2.20 M(+27.2%) | - | - |
| Dec 2002 | $1.73 M(+770.1%) | - | - |
| Dec 2001 | $198.80 K(-86.3%) | - | - |
| Dec 2000 | $1.45 M(-34.4%) | - | - |
| Dec 1999 | $2.22 M(+536.8%) | - | - |
| Dec 1998 | $348.10 K | - | - |
FAQ
- What is Silence Therapeutics annual revenue?
- What is the all time high annual revenue for Silence Therapeutics?
- What is Silence Therapeutics annual revenue year-on-year change?
- What is Silence Therapeutics quarterly revenue?
- What is the all time high quarterly revenue for Silence Therapeutics?
- What is Silence Therapeutics quarterly revenue year-on-year change?
- What is Silence Therapeutics TTM revenue?
- What is the all time high TTM revenue for Silence Therapeutics?
- What is Silence Therapeutics TTM revenue year-on-year change?
What is Silence Therapeutics annual revenue?
The current annual revenue of SLN is $31.57 M
What is the all time high annual revenue for Silence Therapeutics?
Silence Therapeutics all-time high annual revenue is $31.57 M
What is Silence Therapeutics annual revenue year-on-year change?
Over the past year, SLN annual revenue has changed by +$9.90 M (+45.69%)
What is Silence Therapeutics quarterly revenue?
The current quarterly revenue of SLN is $1.49 M
What is the all time high quarterly revenue for Silence Therapeutics?
Silence Therapeutics all-time high quarterly revenue is $15.74 M
What is Silence Therapeutics quarterly revenue year-on-year change?
Over the past year, SLN quarterly revenue has changed by -$1.12 M (-43.00%)
What is Silence Therapeutics TTM revenue?
The current TTM revenue of SLN is $20.58 M
What is the all time high TTM revenue for Silence Therapeutics?
Silence Therapeutics all-time high TTM revenue is $34.79 M
What is Silence Therapeutics TTM revenue year-on-year change?
Over the past year, SLN TTM revenue has changed by -$10.79 M (-34.39%)